drugset / Trial / NCT05809687
Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 3 study to evaluate the efficacy and safety of DKP21102\_B Added on to DKP21102\_A Compared with DKP21102\_A
Timeline
- Start
- 2025-01-01
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
Outcome
Outcome not reported
Stopped: “The clinical trial was withdrawn due to a commercial decision.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DKP21102_B | Unknown | — | — |
| Background | DKP21102_A | Unknown | — | — |